0001181431-12-026762.txt : 20120501 0001181431-12-026762.hdr.sgml : 20120501 20120501170248 ACCESSION NUMBER: 0001181431-12-026762 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120501 FILED AS OF DATE: 20120501 DATE AS OF CHANGE: 20120501 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CROWLEY Richard CENTRAL INDEX KEY: 0001352961 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 12801576 MAIL ADDRESS: STREET 1: IMCLONE SYSTEMS INCORPORATED STREET 2: 180 VARICK STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd343595.xml X0305 4 2012-05-01 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001352961 CROWLEY Richard SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER BLVD. EAST BRUNSWICK NJ 08816 0 1 0 0 EVP Biopharmaceutical Operatio Common Stock, $.01 par value per share 2012-05-01 4 S 0 9200 2.35 D 343800 D These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on April 30, 2011. /s/ Irina Ishak for Richard Crowley 2012-05-01